YDEALIS

Therapeutic areas: broad experience, deep oncology expertise

Over 25 years of studies I have worked on more than 30 indications, with particularly deep experience in oncology, medical devices and cardiology.

Oncology

Assessing the efficacy and safety of new cancer treatments, from first-in-human to marketing authorisation:

  • Ovarian cancer (high-grade serous)
  • Breast cancer, including triple-negative
  • Non-small cell and small cell lung cancer
  • Prostate cancer
  • Pancreatic cancer
  • Colorectal cancer
  • Kidney cancer
  • Hepatocellular carcinoma, radioembolisation
  • Melanoma, including adjuvant
  • Lymphoma

Haematology

Blood cancers and vascular conditions:

  • Relapsed or refractory multiple myeloma
  • Chronic myeloid leukaemia
  • Venous thromboembolic events
  • Superficial vein thrombosis

Medical devices

Performance and safety evaluation, contribution to CE marking:

  • Pericardial bioprosthesis (aortic valve)
  • Abdominal aortic endoprostheses
  • Severe aortic and mitral stenosis
  • Heart failure
  • Laser immuno-thermotherapy
  • Peritoneal dialysis
  • Blood pressure measurement

Cardiology

Contributing to cardiovascular research:

  • Hypertension
  • Valvular heart disease
  • Coronary artery bypass grafting

Vaccines and immunology

Involved in the clinical development of:

  • Influenza A (H1N1) vaccine
  • Influenza A (H5N1) vaccine
  • Seasonal influenza vaccine
  • Individualised mRNA cancer vaccine
  • Cellular immunity

Other areas

Phase II to IV studies in:

  • Respiratory: asthma, COPD
  • Neurology: Parkinson’s disease
  • Rheumatology: rheumatoid arthritis
  • Dermatology: bacterial and parasitic infections
  • Psychiatry: adult depression
  • Urology
  • Dentistry: chronic periodontitis

A study to start, a site to take over, an audit to prepare?

Tell me what you need: I reply within 2 business days with my availability and a first estimate.

Discuss your study +33 6 12 37 70 58 chenard.estelle@ydealis.fr